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Editorial explains why electrophysical
agents are still important in
physiotherapy education. (Comment on
Laakso EL et al, Australian Journal of
Physiotherapy 48: 251-254.)
The recent Editorial by Laakso et al (2002) is, quite simply,
brilliant. The authors are to be commended for their
insight, foresight and courage in writing such an editorial
in the face of mounting criticism about the use and
inclusion of electrophysical agents in physiotherapy
practice and education. 
Reading this editorial gave me comfort and hope. Comfort
from the fact that these authors not only know their stuff,
but they have the research, publications, and expertise to
back them up. They are not shooting blindly or randomly
from the hip. These are well read and well respected
researchers, educators and writers. It gave me hope because
as an educator myself, teaching electrophysical agents for
the past 21 years, I have often felt I am in an uphill battle
against the manual therapists and non-electrotherapy users
in my profession. I have been told that more articles and
research projects state that placebo is more effective than
TENS or ultrasound than there are citing effectiveness. I
have been told that electrophysical agents should be either
dropped or severely cut back in entry-level physiotherapy
curricula. However, those same critics cannot show me
evidence that Maitland is more effective than Kaltenborn or
Paris or McKenzie, or even more effective than no manual
therapy, yet the physiotherapy world is rampant with
manual therapy courses and teaching gurus. Where is the
evidence that Sahrmann techniques really work? 
I constantly scour the literature for articles and research
studies that are done well and that examine the use of
electrophysical agents from a clinical point of view. How
will this agent help me treat my patient - or will it? If the
article does not have any clinical relevance, then I wonder
how can I make it useful to my students? So what if
ultrasound makes nerve conduction velocity increase? How
will that help my patient? However, if an article states that
ultrasound can heat connective tissue, and that heat helps to
increase tissue extensibility with stretching and exercise,
then ultrasound can, and will, remain a part of my
treatment program for that patient.
These authors have helped me to explain to my students
why we teach electrophysical agents and why they are still
an important part of physiotherapy education They have
articulated not only the need to keep electrophysical agents
as part of entry-level curricula, but also the need to keep
them as part of a physiotherapist’s treatment approach.
I am excited and looking forward to sharing these authors’
insights and thoughtful reasoning with my fellow
electrophysical agents instructors in Canadian
physiotherapy programs.
Sandy Rennie
University of Alberta, Edmonton, Canada
Selective citation did not advance
debate on electrophysical agents.
(Comment on Laakso EL et al, Australian
Journal of Physiotherapy 48: 251-254.)
The recent editorial by Laakso and colleagues argued that
there was sufficient evidence to justify the continued
inclusion of electrophysical agents as a major study area
within entry-level curricula. They stated that “despite the
barriers, there are some positive, high quality systematic
reviews supporting the use of electrophysical agents…”. In
support of this assertion, they cited a Cochrane review
(Flemming and Cullum 2002a). My view is that the citation
of this review to support their assertion is quite misleading
because it seems contrary to the reviewers’ conclusions. 
The Flemming and Cullum review located seven low
quality trials, so pooling was not performed, with none of
the individual trials finding a difference in healing rates in
favour of ultrasound. Flemming and Cullum suggested that
their results had the following implications for practice: 
“There is insufficient evidence in this review to support the
routine use of therapeutic ultrasound in practice. The
available evidence does suggest a benefit of ultrasound
therapy in the healing venous leg ulcers. However due to
the poor quality of the studies included in the review this
effect needs interpreting with caution. As all of the studies
are underpowered the effect estimates are extremely
imprecise.”
In the same issue of the Cochrane Library, Flemming and
Cullum published four other reviews of electrophysical
agents for the treatment of skin lesions and the implications
for practice from each review are reproduced below:  
1. “There is no reliable evidence of benefit of using
electromagnetic therapy in the treatment of pressure
sores. The possibility of benefit or harm cannot be
ruled out due to the small number of trials with
methodological limitations and small numbers of
participants.” 
2. “There is insufficient evidence from RCTs to support
the routine use of electromagnetic therapy in
practice.”
3. “There is insufficient evidence in this review to give
a clear direction for practice. There is no evidence of
a benefit of lasers on leg ulcer healing, though there
is not clear evidence of no benefit as the trials are
small and of poor quality.”
4. “There is no evidence of a benefit of using ultrasound
therapy in the treatment of pressure sores. The
possibility of a beneficial or a harmful effect cannot
be ruled out due to the small number of trials with
methodological limitations and small numbers of
participants.”
My letter should not be seen as support for those in this
debate who wish to abandon the use of electrophysical
agents. My position is that the only meaningful way to
eventually resolve this debate is to carefully consider all the
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available evidence. The Editorial by Laakso and colleagues
has failed to advance the debate because it has not done
this. 
Chris Maher
The University of Sydney
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Continued research into electrophysical
agents is the way forward. (Reply to
Maher C, Australian Journal of
Physiotherapy 49: 65-66)
We thank Dr Maher for his interest in the Editorial in which
we argued for the continued inclusion of electrophysical
agents (EPAs) in the entry-level physiotherapy curricula
(Laakso et al 2002, Maher 2003). Our argument was
predicated on the existing evidence, clinical practices and
use of EPAs, and on safety issues. All aspects are integral
to our argument and to current discussions. 
The Editorial devoted considerable space to the problem of
obtaining adequate evidence. This included the decisions
about what constitutes quality evidence, and how evidence
is obtained and evaluated. Dr Maher’s letter argued that the
only way of “resolv(ing) this debate is to carefully consider
all the available evidence”. We agree and argued precisely
for this to precede decisions about EPAs in entry-level
curricula. However, we also discussed our concerns
regarding the current lack of high quality studies
investigating the clinical uses of EPAs and the problems in
relying on databases that depend on systematic reviews of
randomised controlled trials (RCTs), such as PEDro or the
Cochrane Library. We also discussed some inherent
problems in EPA research (eg dosage-related issues) and
the need to consider basic and applied research. Given the
extent of our discussion, we are puzzled as to why Dr
Maher is reporting Cochrane Library entries on some EPAs
and skin disorders, and think the choice somewhat
disingenuous. 
We welcome the opportunity of continuing this debate and
look forward to continued discussion of the relevant
aspects of the issue of EPAs in entry-level curricula. At this
stage though, we venture to repeat our suggestion of a way
forward: promote all types of research into EPAs. This is
also consistent with the need for a generally more
substantial evidence base for decision-making in
physiotherapy practice as a whole. And, if we then discuss
all the relevant evidence, not just reviews of RCTs, perhaps
we can then agree on which EPAs are clinically effective
and which are not. This may then assist educators in their
decisions as to what can and cannot justifiably be included
in future curricula.   
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